Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003665 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00002754 | Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors | completed | Phase 1 | 6 | Duke UniversityOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00004148 |
| Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma |
| completed |
| Phase 1 |
| 12 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Feb 11, 2013 |
| clinicaltrials |
| NCT00005961 | O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00017316 | Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003556 | Vaccine Therapy in Treating Patients With Melanoma | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT01782508 | A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma | unknown | Phase 2 | 40 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00003911 | S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases | terminated | Phase 2 | 2 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 31, 2013 | clinicaltrials |
| NCT01216787 | RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00006243 | Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma | completed | N/A | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00036764 | BMS-247550 in Treating Patients With Stage IV Melanoma | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00006003 | SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated | terminated | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00072345 | Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00072163 | Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00004152 | PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00004250 | Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery | completed | Phase 2 | 35 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00005949 | Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00024011 | PS-341 in Treating Patients With Metastatic Malignant Melanoma | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00110032 | Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors | terminated | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00204516 | Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens | completed | Phase 1 / Phase 2 | 31 | University Hospital TuebingenOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00204594 | Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 | completed | Phase 1 / Phase 2 | 1 | University Hospital TuebingenOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00119249 | Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 74 | National Cancer Institute (NCI)NIH | 1 | Jan 15, 2013 | clinicaltrials |
| NCT00509496 | Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes | terminated | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jan 15, 2013 | clinicaltrials |
| NCT00970996 | Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma(BCAA) | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00509288 | Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes | completed | Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Dec 28, 2012 | clinicaltrials |
| NCT00001832 | Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma | completed | Phase 2 | 170 | National Cancer Institute (NCI)NIH | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00003802 | Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma | completed | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00348088 | Melanoma Biomarker Study | completed | — | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00085579 | Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | withdrawn | Phase 2 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT00627419 | A Study Evaluating the Safety and Antitumor Activity of IPI-504, in Patients With Metastatic Melanoma | terminated | Phase 2 | 1 | Infinity Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 10, 2012 | clinicaltrials |
| NCT01308762 | A Clinical Study, to Evaluate the Safety and Tolerability of Intradermal IMM-101 in Adult Melanoma Cancer Patients | completed | Phase 1 | 19 | Immodulon Therapeutics LtdINDUSTRY | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00835419 | Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression(ENVER) | completed | Phase 2 | 12 | Piramal Enterprises LimitedINDUSTRY | 3 | Dec 4, 2012 | clinicaltrials |
| NCT00324623 | Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma | completed | Phase 1 | 8 | Prof. Serge LeyvrazOTHER | 1 | Nov 20, 2012 | clinicaltrials |
| NCT00328861 | Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer | completed | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Nov 5, 2012 | clinicaltrials |
| NCT00924001 | Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma | terminated | Phase 1 / Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Oct 25, 2012 | clinicaltrials |
| NCT00059475 | Peptide Vaccination for Patients at High Risk for Recurrent Melanoma | completed | Phase 2 | 138 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00273910 | Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma | completed | Phase 2 | 104 | National Cancer Institute (NCI)NIH | 1 | Oct 19, 2012 | clinicaltrials |
| NCT00314106 | Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00492440 | Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | terminated | Phase 1 | 9 | Cytheris SAINDUSTRY | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00862914 | Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi | completed | — | 30 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01444560 | miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi | completed | — | 21 | Ruhr University of BochumOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01331915 | Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients(THERAVAC) | unknown | Phase 1 / Phase 2 | 23 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT00785369 | In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis | completed | N/A | 441 | Lucid, Inc.INDUSTRY | 1 | Oct 3, 2012 | clinicaltrials |
| NCT00512798 | Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma | terminated | Phase 1 / Phase 2 | 47 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT01013623 | Stage IV Surgery Versus Best Medical Therapy(STG4SURG) | terminated | Phase 3 | 12 | Saint John's Cancer InstituteOTHER | 5 | Sep 26, 2012 | clinicaltrials |
| NCT00005615 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | completed | Phase 1 / Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00020839 | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain | terminated | Phase 3 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00036816 | Vaccine Therapy in Treating Patients With Melanoma of the Eye | terminated | Phase 3 | 13 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00110123 | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma | terminated | Phase 3 | 171 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 28, 2013source: clinicaltrials